Anavex was my first biotech investment. My portfolio currently holds a few other equally sizable biotech investments. I project Anavex to pay out in 2025, and the other two in 2026 and 2027.
I do not think I will ever buy another biotech again, because I've seen the worst of humanity on these message boards. It takes a special type of a*$hole to bet against anything that may offer a glimmer of hope to sick kids, purely because the ease of short-term profit outweighs long-term decency.
I'm not against short selling stocks. I believe it provides necessary liquidity and disincentivizes crooked CEOs from taking advantage of shareholders. But I am starting to think shorting biotechs with market caps under $2B should be illegal, and instead the SEC ought to step up enforcement of these companies to make sure they aren't misleading investors.
Market Data 
Markets 
AI
